Zentiva, a.s. (BSSE: 1SKF401E)
Health Care · Pharmaceuticals · SK
€33.20
0.00% today · +10.7% 1Y
Public summary
A free snapshot of Zentiva, a.s., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Zentiva, a.s. (BSSE: 1SKF401E) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $59.98M.
Over the last twelve months the share price has gained 10.7%, trading between 29.00 and 33.20.
Tweenvest scores Zentiva, a.s. across four factors: quality 73/100, value 32/100, growth 0/100. Its strongest factor is quality.
1SKF401E price history
Key figures
- Market cap
- $59.98M
- Revenue (TTM)
- $41.42M
- P/E
- 23.55
- EPS
- 1.41
- Dividend yield
- —
- Beta (5Y)
- 0.29
- 52-week high
- €33.20
- 52-week low
- €29.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.62M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| High Tech Pharm Co., Ltd.KOSDAQ: A106190 | $61.90M | ₩7,760.00 | 0.00% |
| Merdury Biopharmaceutical CorporationTPEX: 6932 | $61.17M | NT$4.99 | -4.22% |
| Verrica Pharmaceuticals Inc.NasdaqCM: VRCA | $61.16M | $3.56 | -4.30% |
| KOREA PHARMA Co., Ltd.KOSDAQ: A032300 | $61.03M | ₩7,480.00 | +0.27% |
| Island Pharmaceuticals LimitedASX: ILA | $59.63M | AU$0.30 | +3.45% |
| Enzymatica AB (publ)OM: ENZY | $59.60M | Skr2.46 | -1.20% |
| Sam-A Pharm. Co., LtdKOSDAQ: A009300 | $59.45M | ₩13,020.00 | +0.70% |
| Poolbeg Pharma PLCAIM: POLB | $59.06M | £0.06 | 0.00% |